Evidence map›Paper›PMID 25617899›Full record

ArticlePloS one2015

Enhanced amphiphilic profile of a short β-stranded peptide improves its antimicrobial activity.

Giorgia Manzo, Mariano A Scorciapino, Parvesh Wadhwani, Jochen Bürck, Nicola Pietro Montaldo, Manuela Pintus, Roberta Sanna, Mariano Casu, Andrea Giuliani, Giovanna Pirri and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. The Anti-Microbial Peptide (Lin-SB056-1)Antibiotics (Basel, Switzerland) · 2020
    Article
  14. HBiomaterials science · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Giorgia ManzoDepartment of Chemical and Geological Sciences, University of Cagliari, Cittadella Universitaria, I-09042 Monserrato (CA), Italy.
Mariano A ScorciapinoDepartment of Chemical and Geological Sciences, University of Cagliari, Cittadella Universitaria, I-09042 Monserrato (CA), Italy.
Parvesh WadhwaniInstitute of Biological Interfaces (IBG-2), Karlsruhe Institute of Technology (KIT), POB 3640, 76021 Karlsruhe, Germany.
Jochen BürckInstitute of Biological Interfaces (IBG-2), Karlsruhe Institute of Technology (KIT), POB 3640, 76021 Karlsruhe, Germany.
Nicola Pietro MontaldoDepartment of Biomedical Sciences, University of Cagliari, Cittadella Universitaria, I-09042 Monserrato (CA), Italy.
Manuela PintusDepartment of Biomedical Sciences, University of Cagliari, Cittadella Universitaria, I-09042 Monserrato (CA), Italy.
Roberta SannaDepartment of Chemical and Geological Sciences, University of Cagliari, Cittadella Universitaria, I-09042 Monserrato (CA), Italy.
Mariano CasuDepartment of Chemical and Geological Sciences, University of Cagliari, Cittadella Universitaria, I-09042 Monserrato (CA), Italy.
Andrea GiulianiResearch & Development Unit, Spider Biotech S.r.l., I-10010 Colleretto Giacosa (TO), Italy.
Giovanna PirriResearch & Development Unit, Spider Biotech S.r.l., I-10010 Colleretto Giacosa (TO), Italy.
Vincenzo LucaDipartimento di Scienze Biochimiche, "A. Rossi Fanelli", Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza Università di Roma, Rome, Italy.
Anne S UlrichInstitute of Biological Interfaces (IBG-2), Karlsruhe Institute of Technology (KIT), POB 3640, 76021 Karlsruhe, Germany; Institute of Organic Chemistry, Karlsruhe Institute of Technology (KIT), Fritz-Haber-Weg 6, 76131 Karlsruhe, Germany.
Andrea C RinaldiDepartment of Biomedical Sciences, University of Cagliari, Cittadella Universitaria, I-09042 Monserrato (CA), Italy.
University of Cagliari · ITKarlsruhe Institute of Technology · DEGiotto Biotech (Italy) · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SB056 is a novel semi-synthetic antimicrobial peptide with a dimeric dendrimer scaffold. Active against both Gram-negative and -positive bacteria, its mechanism has been attributed to a disruption of bacterial membranes. The branched peptide was shown to assume a β-stranded conformation in a lipidic environment. Here, we report on a rational modification of the original, empirically derived linear peptide sequence [WKKIRVRLSA-NH2, SB056-lin]. We interchanged the first two residues [KWKIRVRLSA-NH2, β-SB056-lin] to enhance the amphipathic profile, in the hope that a more regular β-strand would lead to a better antimicrobial performance. MIC values confirmed that an enhanced amphiphilic profile indeed significantly increases activity against both Gram-positive and -negative strains. The membrane binding affinity of both peptides, measured by tryptophan fluorescence, increased with an increasing ratio of negatively charged/zwitterionic lipids. Remarkably, β-SB056-lin showed considerable binding even to purely zwitterionic membranes, unlike the original sequence, indicating that besides electrostatic attraction also the amphipathicity of the peptide structure plays a fundamental role in binding, by stabilizing the bound state. Synchrotron radiation circular dichroism and solid-state 19F-NMR were used to characterize and compare the conformation and mobility of the membrane bound peptides. Both SB056-lin and β-SB056-lin adopt a β-stranded conformation upon binding POPC vesicles, but the former maintains an intrinsic structural disorder that also affects its aggregation tendency. Upon introducing some anionic POPG into the POPC matrix, the sequence-optimized β-SB056-lin forms well-ordered β-strands once electro-neutrality is approached, and it aggregates into more extended β-sheets as the concentration of anionic lipids in the bilayer is raised. The enhanced antimicrobial activity of the analogue correlates with the formation of these extended β-sheets, which also leads to a dramatic alteration of membrane integrity as shown by 31P-NMR. These findings are generally relevant for the design and optimization of other membrane-active antimicrobial peptides that can fold into amphipathic β-strands.

Indexed as

Anti-Infective AgentsCircular DichroismErythrocytesEscherichia coliHemolytic AgentsHumansMicrobial Sensitivity TestsNuclear Magnetic Resonance, BiomolecularPeptidesProtein Structure, SecondaryPseudomonas aeruginosaSequence Analysis, ProteinStaphylococcus aureusSurface-Active AgentsAnti-Infective AgentsHemolytic AgentsPeptidesSurface-Active Agents

Identifiers

PMID25617899
PMCPMC4305290
OpenAlexW2057632290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.